X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Active Ingredient Identification Made Faster Via UHPT Method

Content Team by Content Team
22nd July 2023
in Drug Development, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

In the late 1950s and 1960s, thalidomide, a drug given to pregnant women to alleviate morning sickness, caused a tragic outcome. Over 12,000 babies were born with severe malformations, like shortened limbs, due to the drug’s side effects. These deformities were caused by the drug’s racemic mixture of two mirror-image forms. Understanding the molecular structures of compounds is vital for comprehending biological processes and developing effective drugs. Nuclear magnetic resonance spectroscopy (NMR) plays a significant role in this research by interpreting frequency signals. However, until recently, selectively measuring carbon nuclei signals associated with specific hydrogen atoms in a single measurement posed a challenge.

However, there is good news. Doctors in Korea have introduced a groundbreaking NMR method called the ultraselective heteronuclear polarization transfer method (UHPT). Before the UHPT method, NMR equipment allowed for selective measurement of specific hydrogen nuclei signals but lacked rapid measurement of carbon nuclei signals, leading to unsatisfactory resolution of hydrogen-carbon NMR signals. Additionally, it hindered the identification of chemical structures in pharmaceutical raw materials and potentially toxic drugs.

Thanks to the UHPT method, the doctors successfully distinguished carbon nuclei associated with specific hydrogen atom nuclei in a single measurement, even amid complex carbon-carbon NMR signals, achieving a signal resolution of several hertz (Hz). They used this method to analyze the structures of complex natural products like the anticancer drug dactinomycin, which comprises optical isomers of amino acids, and accurately assign the structure of the fungicide iprovicarb, a mixture of diastereoisomers.

This novel method is not only faster and more accurate than conventional approaches but also economically efficient. The UHPT method significantly reduces the measurement time needed for ultra-high field NMR equipment, achieving equivalent NMR signal resolution approximately one-fifth of the time.

As per insights, this new NMR method can become a standard analysis technique for identifying and standardizing active ingredients in the natural product bio industry. By using this method to identify the structure of partial particulate matter, which plays a crucial role when it comes to determining the efficacy and safety of drugs, it is expected to contribute significantly to the development of the natural product bio industry and address challenges in drug development processes.

Previous Post

Breakthrough Cell & Gene Therapies To Transform Healthcare

Next Post

Combating Antibiotic Resistance With AI & Machine Learning

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Combating Antibiotic Resistance With AI & Machine Learning

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In